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Abstract
Antimicrobial consumption is one of the major contributing factors facilitating the development and maintenance of
bacteria exhibiting antimicrobial resistance. Plasmid-mediated quinolone resistance (PMQR) genes, such as the qnr family,
can be horizontally transferred and contribute to reduced susceptibility to fluoroquinolones. We performed an
observational study, investigating the copy number of PMQR after antimicrobial therapy. We enrolled 300 children
resident in Ho Chi Minh City receiving antimicrobial therapy for acute respiratory tract infections (ARIs). Rectal swabs were
taken on enrollment and seven days subsequently, counts for Enterobacteriaceae were performed and qnrA, qnrB and qnrS
were quantified by using real-time PCR on metagenomic stool DNA. On enrollment, we found no association between age,
gender or location of the participants and the prevalence of qnrA, qnrB or qnrS. Yet, all three loci demonstrated a
proportional increase in the number of samples testing positive between day 0 and day 7. Furthermore, qnrB demonstrated
a significant increase in copy number between paired samples (p,0.001; Wilcoxon rank-sum), associated with non-
fluoroquinolone combination antimicrobial therapy. To our knowledge, this is the first study describing an association
between the use of non-fluoroquinolone antimicrobials and the increasing relative prevalence and quantity of qnr genes.
Our work outlines a potential mechanism for the selection and maintenance of PMQR genes and predicts a strong effect of
co-selection of these resistance determinants through the use of unrelated and potentially unnecessary antimicrobial
regimes.
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Introduction
Appropriate antimicrobial usage in the management of
infectious diseases is an important issue for patients and
administering clinicians. The issue is particularly relevant in many
low and middle income countries, where the sale of antimicrobials
is often unrestricted [1,2,3]. It is apparent that the sustained usage
of some antimicrobial classes has, over time, reduced the effect of
these drugs on once susceptible pathogens and encouraged the
selection of resistant bacteria [4,5,6]. The implications of
antimicrobial resistant pathogenic bacteria are clear, including
treatment failure, increasing treatment costs and protracted
therapy [7]. Furthermore, antimicrobial resistant organisms, or
the mobile elements carrying the resistance genes, can be
transmitted to other individuals and organisms, respectively,
increasing the proportion of antimicrobial resistant organisms
circulating in the general population [8,9].
Plasmid-mediated quinolone resistance (PMQR) determinants,
in the form of qnr genes, were first reported in 1998 in a clinical K.
pneumoniae isolate from a patient with a urinary tract infection in
the USA [10]. In less than ten years, the reported prevalence of qnr
genes (qnrA, qnrB, qnrS, qnrC and qnrD) has increased dramatically ,
reported globally across a spectrum of bacterial species, such as E.
coli, Klebsiella pneumoniae [11,12,13]. The phenotype conferred by
Qnr determinants is generally low level resistance to fluoroquin-
olones, yet they appear to encourage additional fluoroquinolone
resistance mechanisms, subsequently resulting in high level
resistance [10]. Our work in Ho Chi Minh City (HCMC),
Vietnam, and the work of others, has shown that qnr genes are
common in commensal organisms and are carried by mobile
elements harbouring multiple antimicrobial resistance genes
[14,15,16]. Furthermore, we have suggested that qnr genes are
co-selected by the use of non-quinolone antimicrobials and we
have hypothesized that the use of antimicrobials, other than
fluoroquinolones, plays a critical role in the selection and
maintenance of qnr genes in the commensal human gut flora.
Acute respiratory tract infections (ARIs) are the most common
infection in children in developed and developing countries and
are the leading cause of death in children less than five years of age
[17]. A meta-analysis highlighted the global ARI disease burden, ,
estimating that 1.9 million (95% Confidence Interval [CI] 1.6–2.2
million) children died from ARIs in 2000, of which 70% of deaths
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were in Africa and Southeast Asia [17]. Viruses are the dominant
etiologic agents of ARIs, responsible for approximately 60% of all
cases [17]. However, because an etiological diagnosis is not
normally established quickly, antimicrobials are typically the
mainstay of empirical ARI treatment [18]. Here, we have
developed several real-time PCR assays to detect and enumerate
qnr genes and quantified these loci in paired rectal swabs from
children with symptoms of ARI prior to, and after seven days of,
antimicrobial treatment.
Materials and Methods
Participants, enrolment and ethical approval
Children presenting to the outpatient department of Children’s
Hospital 1 in HCMC between April and November 2009 were
eligible for enrolment in this study. The inclusion criteria were: less
than 16 years of age, symptoms of ARI, not admitted to hospital,
living in HCMC, prepared to come back for follow-up at day 7
and informed written consent given by a parent or a legal
guardian. The age, demographics and prescribed antimicrobials
were recorded at the time of enrolment (Day 0), after the
consultation and a written prescription from the clinician making
the medical assessment. All antimicrobials were prescribed at the
discretion of the treating clinicians. Rectal swabs from all recruited
children were collected on enrolment (prior to antimicrobial
therapy) and on Day 7 (after antimicrobial therapy). Rectal swabs
were stored in 1 ml of sterile saline, which is commonly used for
transporting samples and making dilutions of Enterobacteriaceae.
These solutions were processed for microbiology on the day of
collection and were stored at 280uC until molecular analysis. This
study was performed in accordance with the declaration of
Helsinki and was granted ethical approval by Children’s Hospital
1 in HCMC, Vietnam and the Oxford Tropical Research Ethics
Committee (OxTREC), in the United Kingdom. Informed written
consent was given by a parent or a legal guardian.
Sample processing and colony counting
Ten-fold serial dilutions (from 1021 to 1028) were made from all
rectal swabs on the day of collection. Fifty microlitres of each
dilution was inoculated onto MacConkey agar (Oxoid, UK) plates
and incubated at 37uC overnight. The number of bacterial
colonies on each plate was enumerated and plates containing
between 30 to 300 colonies were used to calculate the CFU ml21.
After microbiological assessment, the fecal samples were
processed in batches (Day 0 and Day 7 of the same children) to
ensure limited experimental variation. We compared the quality of
extracted DNA using three DNA extraction methods, DNAeasy
(QIAGEN, USA), QIAam DNA Stool mini kit (QIAGEN, USA)
and the nucliSENS EasyMag system (bioMe´rieux, Mercy l’E´toile,
France). The nucliSENS EasyMag system demonstrated the
highest quantity, quality and reproducibility. As a result, after
addition of the internal control, total nucleic acid was extracted
from 200 ml of stool using the nucliSENS EasyMag system,
according to the manufacturer’s instructions, and was eluted in
50 ml of elution buffer.
Primer design and quantitative real-time PCR
The nucleotide sequences of all available full length alleles for
qnrA, qnrB and qnrS were retrieved from NCBI [19], and aligned
using Vector NTI (Invitrogen). Primers and probes for each of the
three loci were designed using Primer Express version 2.0 (Applied
Biosystems Inc.). The specificity of primers and probes was
assessed using BLASTn against the NCBI database and were
synthetized by Sigma-Proligo (Singapore). The primers and probes
were as follows: qnrA; qnrA_RT_F; CAGTTTCGAGGATTG-
CAGTT, qnrA_RT_R, CCTGAACTCTATGCCAAAGC,
qnrA_probe; Fam - AAGGGTGYCACTTCAGCTATGCC –
Tamra; qnrB; qnrB_RT_F; CAGATTTYCGCGGCGCAAG;
qnrB_RT_R; TTCCCACAGCTCRCAYTTTTC, qnr_probe;
Fam - CGCACCTGGTTTTGYAGYGCMTATATCAC –
Tamra; qnrS; qnrS_RT_F; TCAAGTGAGTAATCGTATGTA,
qnrS_RT_R; GTCTGACTCTTTCAGTGAT, qnrS_probe;
Fam – CCAGCGATTTTCAAACAACTCAC – Tamra. An
internal control consisting of PhHV DNA was added to each
sample. Primers and probe for Phocid Herpes Virus (PhHV),
which were used as an internal control, were as previously
described [20].
Real-time PCR was performed using HotStart Taq polymerase
(QIAGEN) on a Chromo4 Real-time PCR machine (Bio-Rad,
Hercules, CA, USA). Reactions were performed in 25 ml volumes,
containing 2.5 ml of 106 buffer, 5 mM of MgCl2, 500 nM of
dNTPs, 400 nM of each primer, 100 nM of probe, 1 U of
HotStart Taq polymerase and 5 ml of DNA template. Optimized
real-time PCR conditions were: one cycle of 95uC for 15 minutes,
followed by 45 cycles of 30 seconds at 95uC, 30 seconds at
annealing temperature for primer pair and probe and 30 seconds
at 72uC. The optimized annealing temperatures were: 52uC for
qnrA, 54uC for qnrB and 55uC for qnrS. A positive PCR signal was
defined as any Ct (threshold cycle) value ,40.
Standard curves
The target genes (qnrA1, qnrB1 and qnrS1) were amplified in their
entirety with previously described primers [21,22,23] and cloned
into pCR2.1-TOPO and transferred into E. coli TOP10 cells using
the TOPO TA Cloning kit (Invitrogen, UK), according to the
manufacturer’s instructions. Plasmids containing a cloned inser-
tion were detected by blue-white colony selection on Luria-Bertani
(LB) agar supplemented with 50 mg/L ampicillin and 40 mg/L
X-gal. Plasmid DNA was extracted using the QIAprep Miniprep
(QIAGEN), digested with XhoI restriction endonuclease (qnrA1,
qnrB1 and qnrS1 do not have XhoI restriction sites), purified
(QIAquick PCR Purification Kit, QIAGEN) and quantified using
a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technol-
ogies, Inc). Concentrations were then converted to copy number.
Ten-fold serial dilutions of plasmid DNA containing the cloned
target insert were used as an external standard for all quantitative
real-time RT PCR experiments.
PCR Reproducibility, linearity and efficiency
The reproducibility of each assay was assessed by calculating the
co-efficient of variance (CV%). The CV calculates the deviation in
the Ct values of selected plasmid DNA concentrations across
multiple amplifications, both in the same run and in different runs.
Intra-assay reproducibility was assessed by comparing the Ct
values generated in the same run of four replicates of each plasmid
concentration. Inter-assay reproducibility was assessed by com-
paring the Ct values generated by four replicates of each plasmid
concentration over a period of four days. Linearity was assessed by
the Ct values of 10-fold serial dilutions of plasmid DNA containing
cloned target sequences (concentrations 56100–56108) and was
calculated by linear regression. Efficiency was again calculated
from the slope of the standard curve, using the formula:
Efficiency = 10(21/slope)21, according to the methods of Rasmus-
sen et al [24].
Internal extraction and positive amplification controls
For optimizing each of the qnr real-time PCR assays, isolates
that we have previously identified as being qnr-positive were used
Co-Selection of Fluoroquinolone Resistance Genes
PLOS ONE | www.plosone.org 2 August 2012 | Volume 7 | Issue 8 | e42919
as positive controls, these were, qnrA1; Klebsiella pneumoniae
K222Ca, qnrB1; Klebsiella pneumoniae K281An and qnrS1; Klebsiella
pneumoniae K35N [25]. Efficiency of nucleic acid extraction and
real-time PCR amplification was monitored in all reactions by
inclusion of the PhHV internal control [20]. Aliquots of post
culture supernatant containing PhHV were prepared. The precise
amount of virus added to the fecal samples was assessed by PCR
titration during the standard curves experiments. The final
dilution and volume was selected on the basis that it reproducibly
produced a Ct value within the range of 30–33, equating to
approximately copies of PhHV added to each sample prior to
nucleic acid extraction. Any amplification run that did not
produce a Ct value between 30 and 33 for PhHV was discarded.
Positive amplification controls with known Ct values for each gene
and ‘no-template negative control’ were included in each
amplification run.
Statistical analysis
The gene copy numbers and the CFU ml21 of Enterobacteriaceae
in each sample was calculated and logarithmically transformed for
analysis using MS excel (Microsoft). The demographic data,
prevalence of qnr genes and copy number of qnr genes between
Day 0 and Day 7 were compared using the Fisher’s exact test,
McNemar’s test and Wilcoxon’s rank-sum test, respectively.
Results were interpreted as statistically significant when p,0.05.
All analyses were performed using R version 2.12.0 program
(Foundation for Statistical Computing, Vienna, Austria).
Results
Validation of quantitative real-time PCR assays for qnr
genes
We developed three real-time PCR assays to quantify the copy
number of qnrA, qnrB and qnrS. Plasmids containing cloned qnrA,
qnrB and qnrS target sequences were used as positive controls for
quantifying amplification. PCR amplicons for cloning were
generated using genomic DNA extracted from bacterial isolates
previously found to be positive for one of the three target loci [25].
The real-time PCR assays were tested on nucleic acid extracted
from 45 enteric organisms previously found to be qnr negative
including, E. coli, Shigella spp., Salmonella spp., Citrobacter spp.,
Enterobacter spp., Pantoea spp., Proteus mirabilis and Klebsiella spp. None
of the three loci demonstrated any unspecific amplification with
any target nucleic acid from any of the tested organisms.
To assess the potential for cross hybridization between the three
gene targets, each PCR assay was performed using template DNA
prepared from each of the qnrA, qnrB and qnrS positive control
strains. These experiments were repeated in triplicate. Each
replicate for all PCR assays produced an identical result and each
assay was specific for the intended target. The detection limit of
each of the three assays was calculated on the basis of fifty
individual Ct values for the diluted plasmid DNA samples,
produced from ten replicates over five days that consistently
generated a positive signal in $95% of reactions. These
concentrations were ,50 copies per reaction of the cloned target
sequences of all three targets.
Reproducibility and linearity
Table 1 shows the results from a series of consecutive standard
curve experiments. These data demonstrate the overall perfor-
mance, intra-assay variation and inter-assay variation of the three
real-time PCR assays. The intra-assay and inter-assay co-efficient
of variance across the three targets ranged from 0.56–2.72%
(.97% reproducibility) and 1.27–2.96% (.97% reproducibility),
respectively, with target copy numbers ranging from 56101 to
56107 copies per reaction. Linearity was assessed by a standard
curve produced from the Ct values generated from amplification
of the 56107 to the 56101 copies per reaction (i.e. seven data
points) and was calculated by linear regression. The linear
regressions of the three standard curves were R2= 0.999 for qnrA,
R2 = 0.999 for qnrB and R2=0.998 for qnrS, indicating a strong
linear correlation between Ct value and target gene concentration.
The efficiencies of the amplifications were 87% for qnrA (95CI; 85–
90%), 91% for qnrB (95CI; 89–92%) and 87% qnrS (95CI; 81–
92%).
Baseline study population characteristics
Three hundred children were enrolled for the purposes of this
study, resulting in a total of 600 rectal swabs. Bacterial colony
counting and quantitative real-time PCR for all three loci were
performed on all 600 samples. For subsequent data analysis we
required accurate PCR amplification and a bacterial colony count
on all 600 stool samples and antimicrobial usage data from each of
the 300 enrolees. We rejected 37 paired samples for the purposes
of our analysis. From these rejected paired samples, 19 samples
had a negative internal control, 16 samples had less than 30
colonies cultured and two enrolees did not have available
antimicrobial usage data. Therefore, paired data from 263
enrolled children were available for analysis.
The resulting baseline data for the detection of qnrA, qnrB and
qnrS on Day 0 from 263 children is shown in Table 2. The children
were resident in 18 different districts in HCMC, which we divided
into three groups based on population density, an a priori variable
that we believed may confound the relationship between local qnr
gene exposure and circulation (Table 2). The median age of
enrolees was 12 months (range: 2 months to 12 years) and the male
to female ratio was 1:0.83. On Day 0, we detected qnrA in 12
Table 1. The validation of quantitative real-time PCR assays
targeting qnrA, qnrB and qnrS.
Variable Target copy number
56107 56106 56105 56104 56103 56102 50
qnrA
Ct value 12.32 16.05 20.58 23.44 27.53 31.3 34.58
Intra-assay CV% 0.75 0.91 0.79 0.74 1.46 2.00 2.72
Ct value 12.41 16.37 20.40 23.42 27.35 31.3 34.39
Inter-assay CV% 1.43 1.57 1.45 2.55 2.90 2.86 2.96
qnrB
Ct value 12.41 16.40 20.60 23.17 27.44 31.35 34.52
Intra-assay CV% 0.65 0.76 0.56 1.22 1.28 1.47 1.91
Ct value 12.41 16.35 20.47 23.46 27.20 31.45 34.37
Inter-assay CV% 1.83 2.19 2.46 1.86 2.12 2.45 2.83
qnrS
Ct value 13.09 16.86 20.12 23.69 27.77 30.72 34.12
Intra-assay CV% 1.38 0.65 1.43 2.02 1.62 1.13 1.59
Ct value 13.28 16.99 20.77 24.18 27.30 31.40 34.56
Inter-assay CV% 2.67 1.27 2.18 2.12 2.09 1.70 2.45
The inter-assay and intra-assay variability were checked on bacterial nucleic acid
extracted from pure culture with and without internal control PhHV. No
differences were observed between these two batches.
CV: Coefficient of variance.
doi:10.1371/journal.pone.0042919.t001
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samples (4.5%), qnrB in 116 samples (44.1%) and qnrS in 196
samples (74.5%). We found no significant association between age,
gender or population density of the participants with qnr gene
prevalence on Day 0 using Fisher’s exact test (Table 2).
Prevalence and quantification of qnr genes in stool
samples from children with ARIs
We compared the proportion of rectal swabs demonstrating a
PCR amplification signal for qnrA, qnrB and qnrS using paired
samples taken on Day 0 and Day 7 (Table 3). All three loci
demonstrated a proportional increase in the number of samples
testing positive for the qnr loci. The percentage of samples testing
positive increased by 4.2%, 24% and 4.2% for qnrA, qnrB and qnrS,
respectively. The comparative difference between these samples
was assessed by McNemar’s test; only qnrB demonstrated a
statistically significant increase (p,0.001).
To compare the number of Enterobacteriaceae in the intestinal
flora before and after the use of antimicrobials, the CFU ml21 of
Enterobacteriaceae on MacConkey agar were calculated. We did not
formally assess a coefficient of variance for the colony counts from
rectal swabs. However, whilst developing this technique for the
purposes of this investigation, 20 samples were tested in triplicate
and the counts were found to have tolerable variation (+/210% of
the primary value). The median CFU ml21 in paired samples
demonstrated a significant increase from 1.266107 (range; 86102
to 96108) on Day 0 to 3.266107 (range 7.86102 to 561011) on
Day 7 (p,0.001, paired Wilcoxon rank-sum) (Table 3).
By the use of a standard curve on each independent run, we
calculated the copy number of qnrA, qnrB and qnrS in the 526 stool
samples. The median copy numbers of qnrA, qnrB and qnrS on Day
0 were 7.46104 (range: 2.66103 to 5.26107), 4.86104 (range:
2.66103 to 7.86107) and 2.86105 (range: 2.76103 to 7.96108),
respectively. The median copy numbers of qnrA, qnrB and qnrS on
Day 7 were 2.26104 (range: 2.76103 to 2.86107), 1.36105 (range:
2.76103 to 4.261010) and 1.16106 (range: 46103 to 2.26109),
respectively. The qnrS gene had the highest copy numbers of the
three-qnr loci on both day 0 and day 7 (Figure 1). After adjusting
copy number for Enterobacteriaceae CFU ml21, qnrB demonstrated a
significant increase between Day 0 and Day 7 (p,0.001, paired
Wilcoxon rank-sum) (Table 3).
Comparing antimicrobial usage and qnr gene copy
number
We stratified the copy numbers of qnrA, qnrB and qnrS in the 263
enrolled children by their prescribed antimicrobial treatment
regimen (Table 4). Twelve different antimicrobials, belonging to
three different classes; b-lactam and b-lactamase inhibitor
combination (amoxicillin-clavulanic acid), cephalosporins (cefa-
clor, cefadroxil, cefixime, ceftriaxone, cefuroxime, cefpodoxime)
and macrolides (azithromycin, erythromycin, roxithromycin,
spiramycin) were used to treat enrolled participants. Notably, no
children were prescribed fluoroquinolones. Seven different anti-
microbial regimens were prescribed, in the form of mono-therapy
or in a combination of two or more antimicrobials (Table 4).
We analysed the CFU ml21 of the Enterobacteriaceae with each
treatment regimen between the two time points. Three groups (co-
amoxiclav, cephalosporin only and both combined) demonstrated
a significant increase in Enterobacteriaceae CFU ml21 between the
two time points (p,0.05) (Table 4). Again we adjusted the gene
copy numbers from day 0 and day 7 for Enterobacteriaceae
CFU ml21 within the treatment regimes. There was a significant
increase in copy number between Day 0 and Day 7 for the qnrA
and qnrB loci in those treated with co-amoxiclav and co-amoxiclav
combined with a cephalosporin (Table 4).
Discussion
PMQR genes stimulate low level resistance to fluoroquinolones,
yet their ability to facilitate other fluoroquinolone resistance
mechanisms and their promiscuity threatens the long-term efficacy
of the fluoroquinolones [10]. There has been intense investigation
of PMQR genes across a wide diversity of bacterial species, with
some studies focusing on detecting qnr, aac(69)-Ib-cr and qepA genes
using real-time PCR or by pyrosequencing in clinical isolates
[26,27,28,29]. Here, for the first time, we have used real-time
PCR to detect and quantify qnr genes in nucleic acid extracted
directly from rectal swabs of patients treated with antimicrobials.
This observational real-time PCR investigation for qnrA, qnrB
and qnrS on paired stool samples from children with ARIs living in
HCMC reveals several new insights into the prevalence and
selection of qnr genes in this location. Notably, the prevalence of
qnrB increased between the day of enrolment and seven days after
antimicrobial therapy, even after stratification by the number of
Enterobacteriaceae. Our data suggest that this increase is related to
selection of qnrB through antimicrobial exposure, either by direct
selection or enrichment of existing qnrB containing organisms in
the gastrointestinal tract. The uptake and maintenance of qnrB is
likely through contaminated food or constant exposure to
organisms with this gene from known environmental sources
[30,31,32]. Moreover, co-existence of qnrB with other resistance
genes, such as blaCTX-M-14 or blaCTX-M-15, on the same plasmid is a
well-known phenomenon [33,34]. In our previous study of qnr
genes in organisms isolated in the hospital and the community in
HCMC, we found that 11%, 12% and 45% of bacterial isolates
from hospitalised individuals were positive for qnrA, qnrB and qnrS,
respectively, and 0.7%, 0.5%, 12% from community isolates were
positive for qnrA, qnrB and qnrS, respectively [25]. Here, we
detected a substantially higher prevalence of the PMQR genes
than before. Explanations for this disparity include the use of
updated primers (i.e. the ability to detect newer alleles); differences
Table 2. Baseline demographic characteristics of participants
and the prevalence of qnr genes prior to antimicrobial
therapy.
Variable qnrA positive qnrB positive qnrS positive
(n=263) (n =263) (n =263)
Sex
Male (n = 144) 6 (4.2%) 67 (46.5%) 111 (77.1%)
Female (n = 119) 6 (5%) 49 (41.2%) 85 (71.4%)
Age
,1 (n = 66) 3 (4.5%) 37 (56.1%) 57 (86.4%)
1 (n = 75) 5 (6.7%) 34 (45.3%) 55 (73.3%)
2 (n = 51) 1 (2%) 20 (39.2%) 34 (66.7%)
3 (n = 43) 2 (4.7%) 19 (44.2%) 31 (72.1%)
.3 (n = 28) 1 (3.6%) 6 (21.4%) 19 (68%)
Population density*
Low (n = 95) 5 (5.3%) 44 (46.3%) 72 (75.8%)
Medium (n = 116) 3 (2.6%) 48 (41.4%) 86 (74%)
High (n = 52) 4 (7.7%) 24 (46.2%) 38 (73.1%)
*Districts within HCMC with population densities ,10,000 (low), 10,000–30000
(medium) and .30,000 people/km2 (high).
doi:10.1371/journal.pone.0042919.t002
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in the target populations (bacterial isolates vs. metagenomic
approach on stool samples); an increased sensitivity of real-time vs.
conventional PCR method; and a difference of four years, which
may reflect a natural increase in the circulation of organisms (and
people) carrying PMQR genes.
There have been several reports related to antimicrobial usage
and an increase in resistant bacteria, yet this is the first describing
evidence of the co-selection of PMQR genes in this manner
[35,36]. Both qnrB and qnrS demonstrated significant copy number
increases between Day 0 and Day 7. Yet, none of the individuals
enrolled in this study were treated with fluoroquinolones and
instead were prescribed amoxicillin/clavulanic acid, macrolides or
cephalosporins. This increase in copy number over the two time
points, apparently via exposure to these antimicrobials, particu-
larly amoxicillin/clavulanic acid or amoxicillin/clavulanic acid
combined with a cephalosporin, substantiates our co-selection
hypothesis. Indeed, additional selection is the most likely
mechanism, as PMQR plasmids frequently contain other
resistance genes, particularly determinants encoding resistance to
b-lactams [37,38,39,40,41]. Our currently unpublished data
related to PMQR plasmids and the genetic background of qnrS1
containing mobile elements in HCMC reveals a predominant
qnrS1-containing transposon type carrying the blaLAP-2 gene, which
also encodes resistance to b-lactams. Additional reports have also
shown an intimate association between qnrA and qnrB with ESBL
genes [14,15,42,43,44].
It is predicted that the number and structure of the bacteria
population in the human gut depends on health status, diet and
Table 3. Comparison of qnr gene prevalence, qnr copy number and CFU ml21 of Enterobacteriaceae in stool samples on
enrolment and seven days after enrolment.
Variable Day 0 Day 7 p value
Prevalence of qnr genes (%)
qnrA 12/263 (4.5%) 23/263 (8.7%) 0.054
qnrB 116/263 (44.1%) 179/263 (68.1%) ,0.001*
qnrS 196/263 (74.5%) 207/263 (78.7%) 0.272
Enterobacteriaceae CFU ml21, median (range)
1.36107 3.36107 ,0.001*
(800–96108) (780–561011)
qnr gene copy number ml21, median (range)
qnrA 7.46104 2.26104 0.102
(2.66103–5.26107) (2.76103–2.86107)
qnrB 4.86104 1.36105 ,0.001*
(2.66103–7.86107) (2.76103–4.261010)
qnrS 2.86105 1.16106 ,0.001*
(2.76103–7.96108) (46103–2.26109)
qnr gene copy number per Enterobacteriaceae CFU ml21, median (range)
qnrA 1.861023 9.161024 0.102
(261025–1.6) (3.661026–0.289)
qnrB 1.261023 4.561023 ,0.001*
(361026–485) (761028–2.16104)
qnrS 1.761022 2.961022 0.226
(161025–1065) (561027–2.86103)
Evaluation of the prevalence of qnr genes, gene copy number, CFU ml21 and qnr gene copy number per CFU. Statistical significance was assessed by McNemar’s test
and paired Wilcoxon rank-sum test.
*Statistically significant (p,0.05).
doi:10.1371/journal.pone.0042919.t003
Figure 1. The median gene copy number of qnrA, qnrB and qnrS
on enrolment and after antimicrobial therapy. Box plots showing
the median and interquartile ranges of qnrA, qnrB and qnrS gene copy
numbers in stool samples collected from children with ARIs on
enrolment (Day 0) and after antimicrobial treatment (Day 7). Statistical
significance between the qnr genes was calculated using the paired
Wilcoxon rank-sum test; significant variation in gene copy number
between the qnr genes is denoted at the head of the figure (*), all p
values,0.001.
doi:10.1371/journal.pone.0042919.g001
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antimicrobial usage [45,46,47]. Here, by using MacConkey agar,
we investigated potential differences in the number of Enterobac-
teriaceae between two time points [48]. It is known that the diversity
and the abundance of organisms in stool is great and includes a
variety of Bacteroides, Clostridia, Fusobacteria and Peptostreptococci
[49,50], all of which may contribute to the overall differences
observed in PMQR gene prevalence and copy number. However,
we observed a significant increase in the CFU ml21 of Enterobac-
teriaceae between the two time points, implying a strong selection of
these organisms, potentially through antimicrobial resistance
enrichment. We found a significant increase in CFU ml21 in
rectal swabs between Day 0 and Day 7 related to three
antimicrobial treatment regimens: amoxicillin/clavulanic acid
only, a cephalosporin only, or amoxicillin/clavulanic acid
combined with a cephalosporin. However, only amoxicillin/
clavulanic acid seemed to influence qnr gene copy number (before
and after adjusting for CFU ml21 of Enterobacteriaceae), implying
that the increase of qnr genes is not only a consequence of
Enterobacteriaceae enrichment but these genes may also be shared by
other bacterial species within the intestinal tract [33]. Our results
clearly show a major shift in qnr gene copy numbers after
antimicrobial therapy, yet our findings are limited by a lack of
control group who did not receive antimicrobials. The results
presented here warrant asking additional questions related to the
effect of antimicrobials on the presence and maintenance of qnr
genes and other antimicrobial resistance genes in the gut flora. We
are currently longitudinally following a cohort of children in
HCMC over a two-year period with and without antimicrobial
treatment to address natural fluctuations of resistance genes and
changes in Enterobacteriaceae.
In conclusion, our data demonstrate an increasing prevalence of
qnrB and an increasing quantity of the qnrB and qnrS genes in the
stools of children with ARIs between enrolment and after seven
days treatment with non-fluoroquinolone antimicrobials. This is
the first study describing an association between the use of non-
quinolone antimicrobials and the increasing relative prevalence in
qnr gene copy number in the gut flora. Our work highlights the
rampant nature of PMQR genes in this locality and suggests
aggressive co-selection of these resistance determinants through
the use of unrelated and potentially unnecessary antimicrobial
treatment regimes.
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